NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
ANI Pharmaceuticals Inc (NASDAQ: ANIP)
ANIP Technical Analysis
5
As on 9th Jun 2023 ANIP STOCK Price closed @ 49.49 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 34.58 & Strong Buy for SHORT-TERM with Stoploss of 41.33 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ANIPSTOCK Price
Open | 49.69 | Change | Price | % |
High | 49.99 | 1 Day | -0.37 | -0.74 |
Low | 49.21 | 1 Week | 4.35 | 9.64 |
Close | 49.49 | 1 Month | 12.20 | 32.72 |
Volume | 52354 | 1 Year | 1.51 | 3.15 |
52 Week High 50.90 | 52 Week Low 23.09 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ANIP Daily Charts |
ANIP Intraday Charts |
Whats New @ Bazaartrend |
ANIP Free Analysis |
|
ANIP Important Levels Intraday
RESISTANCE | 50.99 |
RESISTANCE | 50.51 |
RESISTANCE | 50.21 |
RESISTANCE | 49.92 |
SUPPORT | 49.06 |
SUPPORT | 48.77 |
SUPPORT | 48.47 |
SUPPORT | 47.99 |
ANIP Forecast April 2024
4th UP Forecast | 65.04 |
3rd UP Forecast | 60.05 |
2nd UP Forecast | 56.97 |
1st UP Forecast | 53.89 |
1st DOWN Forecast | 45.09 |
2nd DOWN Forecast | 42.01 |
3rd DOWN Forecast | 38.93 |
4th DOWN Forecast | 33.94 |
ANIP Weekly Forecast
4th UP Forecast | 61.07 |
3rd UP Forecast | 57.36 |
2nd UP Forecast | 55.06 |
1st UP Forecast | 52.77 |
1st DOWN Forecast | 46.21 |
2nd DOWN Forecast | 43.92 |
3rd DOWN Forecast | 41.62 |
4th DOWN Forecast | 37.91 |
ANIP Forecast2024
4th UP Forecast | 107.15 |
3rd UP Forecast | 88.66 |
2nd UP Forecast | 77.23 |
1st UP Forecast | 65.8 |
1st DOWN Forecast | 33.18 |
2nd DOWN Forecast | 21.75 |
3rd DOWN Forecast | 10.32 |
4th DOWN Forecast | -8.17 |
ANI Pharmaceuticals Inc ( NASDAQ USA Symbol : ANIP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ANIP Other Details
Segment | EQ | |
Market Capital | 493649632.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
ANIP Address
ANIP Latest News
ANIP Business Profile
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota. Address: 210 Main Street West, Baudette, MN, United States, 56623
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service